The Inflammatory Breast Cancer Treatment Market was valued at USD 1.2 billion in 2024 and is projected to reach USD 2.5 billion by 2034, registering a CAGR of 7.8%. This growth trajectory is underpinned by several factors, including the rising incidence of inflammatory breast cancer (IBC), advancements in treatment modalities, and increasing awareness regarding early diagnosis and treatment...